Date post: | 06-May-2015 |
Category: |
Health & Medicine |
Upload: | shah-parind |
View: | 4,374 times |
Download: | 0 times |
JOURNAL CLUBJOURNAL CLUB
CALMING THE BIPOLAR STORMCALMING THE BIPOLAR STORM
EPIDEMIOLOGY OF BIOPLAR-1EPIDEMIOLOGY OF BIOPLAR-1
4% OF GENERAL POPULATION 4% OF GENERAL POPULATION SUFFERS FROM BIPOLAR DISORDERSUFFERS FROM BIPOLAR DISORDER
AMONG 18-44 YEARS THE PREVALNCE AMONG 18-44 YEARS THE PREVALNCE IS 6 %IS 6 %
HOSPITAL ADMISSIONHOSPITAL ADMISSION
40% FOR MIXED STATES40% FOR MIXED STATES
25% FOR RAPID CYCLER25% FOR RAPID CYCLER
EPIDEMIOLOGY OF BIOPLAR-2EPIDEMIOLOGY OF BIOPLAR-2
80% OF CASES OF BIPOLAR REMAINS 80% OF CASES OF BIPOLAR REMAINS UNDIAGNOSED OR MISDIAGNOSEDUNDIAGNOSED OR MISDIAGNOSED
MISDIAGNOSIS OF THE BIPOLAR IS A MISDIAGNOSIS OF THE BIPOLAR IS A SERIOUS PROBLMSERIOUS PROBLM
- USUALLY ARE MISDIAGNOSED AS A - USUALLY ARE MISDIAGNOSED AS A UNIPOLAR DEPRESSIONUNIPOLAR DEPRESSION
- ARE GIVEN AN ANTIDEPRESSANT - ARE GIVEN AN ANTIDEPRESSANT WITHOUT A MOOD STABILIZERWITHOUT A MOOD STABILIZER
- CAN WORSEN DISORDER BY INDUCING - CAN WORSEN DISORDER BY INDUCING MANIA AND/OR MIXED MANIC SYMPTOMSMANIA AND/OR MIXED MANIC SYMPTOMS
SYMPTOMS SUGGESTIVE OF SYMPTOMS SUGGESTIVE OF BIPOLAR DISORDERBIPOLAR DISORDER
EARLEY ONSET DEPRESSIONEARLEY ONSET DEPRESSION FREQUENT EPISODESFREQUENT EPISODES POOR OR IDIOSYNCRATIC RESPONSE TO ANTIDEPRESSANTPOOR OR IDIOSYNCRATIC RESPONSE TO ANTIDEPRESSANT THE COURSE AND PRESENTATION OF DEPRESSION THE COURSE AND PRESENTATION OF DEPRESSION
CHANGES OVER TIME; FOR EXAMPLE THEY ARE CHANGES OVER TIME; FOR EXAMPLE THEY ARE PSYCHOMOTOR RETARDED AT ONE POINT AND AGITATED AT PSYCHOMOTOR RETARDED AT ONE POINT AND AGITATED AT ANOTHERANOTHER
DEPRESSION/ANXIETY ARE COMBINED WITH SUBSTANCE DEPRESSION/ANXIETY ARE COMBINED WITH SUBSTANCE ABUSEABUSE
DEPRESSION/ANXIETY ARE COMBINED WITH IMPULSIVITYDEPRESSION/ANXIETY ARE COMBINED WITH IMPULSIVITY CHILDHOOD ONSET OF A MOOD DISORDERCHILDHOOD ONSET OF A MOOD DISORDER EARLY ONSET PSYCHOSIS WITH GOOD SOCIAL FUNCTIONEARLY ONSET PSYCHOSIS WITH GOOD SOCIAL FUNCTION FAMILY HISTORY OF MOOD/SUBSTANCE ABUSE PROBLEMFAMILY HISTORY OF MOOD/SUBSTANCE ABUSE PROBLEM
MIXED BIPOLAR EPISODE-MIXED BIPOLAR EPISODE-INCIDENCEINCIDENCE
Several studies were done to determine Several studies were done to determine the incidence rate of mixed bipolar the incidence rate of mixed bipolar episodesepisodes
The incidence rate ranges between 40% The incidence rate ranges between 40% and 57% of bipolar patientsand 57% of bipolar patients
MIXED BIPOLAR EPISODE-SYMPTOMSMIXED BIPOLAR EPISODE-SYMPTOMS
MIXED BIPOLAR EPISODE-MIXED BIPOLAR EPISODE-SYMPTOMSSYMPTOMS
DSM-IV Criteria for Mixed Bipolar EpisodeDSM-IV Criteria for Mixed Bipolar Episode Meets criteria A of Major Depressive Episode Meets criteria A of Major Depressive Episode
and B of Manic Episode for at least one weekand B of Manic Episode for at least one week Mixed episodes are those where patients Mixed episodes are those where patients
experience both depressive and experience both depressive and manic/hypomanic episodemanic/hypomanic episode
There may be variability of mixed state There may be variability of mixed state symptoms in the same individualsymptoms in the same individual
There can be possible predominance of either There can be possible predominance of either depressive or manic symptoms over time in the depressive or manic symptoms over time in the same individualsame individual
MIXED BIPOLAR EPISODE-MIXED BIPOLAR EPISODE-SYMPTOMSSYMPTOMS
The symptoms like irritability, anxiety, The symptoms like irritability, anxiety, dysphoric mood, and agitation can be dysphoric mood, and agitation can be common symptom in the bipolar patientcommon symptom in the bipolar patient
These symptoms should raise the index of These symptoms should raise the index of suspicion that the patient is in a mixed suspicion that the patient is in a mixed statestate
Life charts are valuable in recognizing and Life charts are valuable in recognizing and managing the most challenging bipolar managing the most challenging bipolar patientpatient
COURSE OF MIXED BIPOLARCOURSE OF MIXED BIPOLAR
Patients with mixed episode has a more severe Patients with mixed episode has a more severe course than those with classic euphoric maniacourse than those with classic euphoric mania
Less frequent remissionsLess frequent remissions Higher rates of recurrenceHigher rates of recurrence More frequent substance abuseMore frequent substance abuse Poorer response to some medicationsPoorer response to some medications More extensive co morbiditiesMore extensive co morbidities Increased potential for suicidal tendenciesIncreased potential for suicidal tendencies
STRATEGIES FOR THE STRATEGIES FOR THE TREATMENT OF BIPOLAR TREATMENT OF BIPOLAR
DISORDERDISORDER
Most bipolar need Most bipolar need medications for their medications for their whole lifewhole life
Tolerability and Tolerability and treatment adherence treatment adherence are essential because are essential because of thatof that
STRATEGIES FOR THE TREATMENT OF BIPOLAR STRATEGIES FOR THE TREATMENT OF BIPOLAR DISORDERDISORDER
STRATEGIES FOR THE STRATEGIES FOR THE TREATMENT OF BIPOLAR TREATMENT OF BIPOLAR
DISORDERDISORDERFirst start treatment with agents of proven First start treatment with agents of proven
efficacyefficacyAdequate dose of the drugs must be usedAdequate dose of the drugs must be usedSometimes combination treatment can Sometimes combination treatment can
lower the dose of the single agentlower the dose of the single agentFamiliarize with new agents and consider Familiarize with new agents and consider
them based on evidence and feasibilitythem based on evidence and feasibilityCollaborate with psychosocial or medical Collaborate with psychosocial or medical
standpointstandpoint
STRATEGIES FOR THE STRATEGIES FOR THE TREATMENT OF BIPOLAR TREATMENT OF BIPOLAR
DISORDERDISORDEROnce a dose and depot preparation for Once a dose and depot preparation for
atypicals can enhance the compliance of atypicals can enhance the compliance of the medicationthe medication
Data are limited for usefulness of ECT in Data are limited for usefulness of ECT in acute maniaacute mania
Some studies have found ECT as effective Some studies have found ECT as effective as atypical antipsychotic in the treatment as atypical antipsychotic in the treatment of maniaof mania
MEDICATIONS MEDICATIONS ACUTE MANIAACUTE MANIA MAINT.MAINT. AC. DEPRESS.AC. DEPRESS.
LithiumLithium LithiumLithium Olanazapine-Olanazapine-fluoxetine combfluoxetine comb
ChlorpromazineChlorpromazine LamotrigineLamotrigine
DivalporexDivalporex OlanazapineOlanazapine
OlanazapineOlanazapine AripiprazoleAripiprazole
RisperidoneRisperidone
QuetiapineQuetiapine
ZiprasidoneZiprasidone
AripiprazoleAripiprazole
CarbamazepineCarbamazepine
FDA APPROVED BIPOLAR FDA APPROVED BIPOLAR TREATMENT OPTION-MOOD TREATMENT OPTION-MOOD
STABILIZERSTABILIZER
MANIAMANIA MIXED MIXED MAINT.MAINT. DEPRESDEPRES
LITHIUMLITHIUM ++ -- - - --
DivalproDivalpro ++ -- -- --
DivaER/DivaER/Carb ERCarb ER
++ ++ __ __
LamotriLamotri __ _ _ ++ __
FDA APPROVED BIPOLAR FDA APPROVED BIPOLAR TREATMENT OPTION-antipsychTREATMENT OPTION-antipsych
MANICMANIC MIXEDMIXED MAINT.MAINT. DEPRESDEPRES
OlanazaOlanazapinepine
++ ++ + + __
RisperiRisperi ++ ++ __ __
QuetiaQuetia ++ __ __ __
ZiprasidZiprasid ++ ++ __ __
AripipraAripipra ++ ++ ++ __
FDA APPROVED BIPOLAR FDA APPROVED BIPOLAR TREATMENT OPTION-otherTREATMENT OPTION-other
ManiaMania MixedMixed MainteMainte DepreDepre
Olanaza/Olanaza/
FluoxetinFluoxetin
__ __ __ ++
Consensus Guidelines: Initial Consensus Guidelines: Initial Treatment Regimen Bipolar ITreatment Regimen Bipolar I
Clinical Clinical
PresentationPresentation
Preferred InitialPreferred Initial
StrategiesStrategies
AlternateAlternate
StrategiesStrategies
Euphoric maniaEuphoric mania MS aloneMS alone
MS + APMS + AP
Add a BZD to other Add a BZD to other agentsagents
AP aloneAP alone
Dysphoric mania or Dysphoric mania or true mixed maniatrue mixed mania
MS + APMS + AP
MS aloneMS alone
Add BZD to either Add BZD to either agentagent
AP aloneAP alone
Combination of two Combination of two MSMS
Mania with history of Mania with history of rapid cyclingrapid cycling
MS + APMS + AP
MS aloneMS alone
Combination of two Combination of two MSMS
Add a BZD to either Add a BZD to either agentagent
AP aloneAP alone
Mania with Mania with psychosispsychosis
MS + APMS + AP
AP aloneAP alone
Add BZD to either Add BZD to either agentagent
MS aloneMS alone
Consensus Guidelines: Inadequate Consensus Guidelines: Inadequate Response to Initial TreatmentResponse to Initial Treatment
InitialInitial
TreatmentTreatment
Preferred Preferred
StrategiesStrategies
Alternate Alternate
StrategiesStrategies
MonotherapyMonotherapy
With a MSWith a MS
Add an AAPAdd an AAP
Add a different MSAdd a different MS
Monotherapy Monotherapy
With an AAPWith an AAP
Add a MSAdd a MS Switch to a MSSwitch to a MS
MS + AAPMS + AAP Replace the current Replace the current AAP with a different AAP with a different AAPAAP
Add different MSAdd different MS
Replace the MS with Replace the MS with different MSdifferent MS
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
LithiumLithium Level ofLevel of
1.2 1.2 mEq/lmEq/l
300-900 300-900 mgmg
0.8-1.2 0.8-1.2 mEq/LmEq/L
++++
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
DVPDVP Oral loadOral load
30 30 mg/kg/dmg/kg/d
250-500 250-500 HS for 2 HS for 2 daysdays
125 125 microgramicrogra/ml/ml
++++
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
DVP ERDVP ER Oral loadOral load
30 30 mg/kg/dmg/kg/d
750 750 mg/daymg/day
125 125 microgramicrogra/ml/ml
__
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
DVPDVP Oral loadOral load
30 30 mg/kg/dmg/kg/d
250-500 250-500 HS for 2 HS for 2 daysdays
125 125 microgramicrogra/ml/ml
++++
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
CBZCBZ 800-800-1000mg1000mg
200 mg 200 mg HS, BID HS, BID or TIDor TID
1600 1600 mg/daymg/day
++
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
ACUTEACUTE ACUTEACUTE ACUTEACUTE MAINT.MAINT.
DRUGDRUG ADULT ADULT DOSE/DOSE/
DAYDAY
STARTSTART
DOSEDOSE
MAX.MAX.
DOSEDOSE
EFFICAEFFICA
IN IN MAINTEMAINTE
CBZ ERCBZ ER 800-800-1000mg1000mg
400 400 mg/daymg/day
1600 1600 mg/daymg/day
++
TREATMENT OF MANIATREATMENT OF MANIALithium and AnticonvulsantLithium and Anticonvulsant
Lamotrigine ( LTG )Lamotrigine ( LTG )
Not recommended for acute Not recommended for acute maniamania
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
AripripraAripriprazolezole
15-30 15-30 mgmg
5-15 5-15 m/daym/day
30 mg30 mg
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
ClozCloz 100-900 100-900 QD or QD or BIDBID
12.5-25 12.5-25 mg BIDmg BID
30 mg30 mg ++
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
OLZOLZ 15-30 15-30 mg QD mg QD or BIDor BID
5-10 mg 5-10 mg HS; also HS; also 40 mg 40 mg disdis
40 mg40 mg ++++
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
QuetiQueti 400-800 400-800 mg QD mg QD or BIDor BID
25-200 25-200 mg HSmg HS
800 mg800 mg __
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
RisRis 1-6 mg1-6 mg 6 mg6 mg __
TREATMENT OF MANIA: TREATMENT OF MANIA: ANTIPSYCHOTIC DOSINGANTIPSYCHOTIC DOSING
AcuteAcute AcuteAcute AcuteAcute Mainten.Mainten.
DrugDrug Adult Adult dose/daydose/day
Starting Starting DoseDose
Max. Max. Rec. Rec. DosesDoses
Efficacy Efficacy
In Maint.In Maint.
TxTx
ZipZip 40-160 40-160 mg QD mg QD or BIDor BID
20-40 20-40 mg BIDmg BID
160 mg160 mg __
Tolerability of Bipolar agentsTolerability of Bipolar agentsOther than antipsychoticsOther than antipsychotics
DrugsDrugs Weight Weight gaingain
CNSCNS EPSEPS DermDerm GIGI
LithiumLithium ++++ ++++++ 00 ++++ ++++++
DivalopDivaloprexrex
++++ ++++ 00 ++ ++++
CabamCabamazepinazepin
++ ++++++ 00 ++++++ ++++
LamotriLamotrigenegene
++ ++ 00 ++++ ==
Consensus Guidelines: Inadequate Consensus Guidelines: Inadequate Response to Initial TreatmentResponse to Initial Treatment
Optimize dose of initial therapy Optimize dose of initial therapy (foundation therapy) before (foundation therapy) before making changemaking change
GUIDELINES FOR MEDICATIONSGUIDELINES FOR MEDICATIONSIN BIPOLAR-1IN BIPOLAR-1
Patient should be taking a therapeutic Patient should be taking a therapeutic dose of a mood stabilizer and that mood dose of a mood stabilizer and that mood stabilizer should be maximized before stabilizer should be maximized before prescribing an antidepressantprescribing an antidepressant
GUIDELINES FOR MEDICATIONSGUIDELINES FOR MEDICATIONSIN BIPOLAR-2IN BIPOLAR-2
Combinations of mood stabilizers be Combinations of mood stabilizers be should be considered as well. If the first should be considered as well. If the first mood stabilizer does not work, consider mood stabilizer does not work, consider adding a second oneadding a second one
Addition of lithium should be considered in Addition of lithium should be considered in patients failing to respond adequately to patients failing to respond adequately to these initial responsethese initial response
GUIDELINES FOR MEDICATIONSGUIDELINES FOR MEDICATIONSIN BIPOLAR-3IN BIPOLAR-3
For classical euphoric and dysphoric and For classical euphoric and dysphoric and mixed mania and rapid cycling:mixed mania and rapid cycling:
Use a mood stabilizer alone or a mood Use a mood stabilizer alone or a mood stabilizer with an atypical are considered stabilizer with an atypical are considered an appropriate first or second line of an appropriate first or second line of treatmenttreatment
GUIDELINES FOR MEDICATIONSGUIDELINES FOR MEDICATIONSIN BIPOLAR-4IN BIPOLAR-4
Treat psychosis properlyTreat psychosis properly
A good core mood stabilizer, even in face A good core mood stabilizer, even in face of psychosis, should treat the whole of psychosis, should treat the whole affective syndromeaffective syndrome
If the patient failed to respond to initial If the patient failed to respond to initial treatment with a monotherapy with a mood treatment with a monotherapy with a mood stabilizer, add an atypical or add a stabilizer, add an atypical or add a different mood stabilizerdifferent mood stabilizer
Until the patient is clearly on a standard Until the patient is clearly on a standard mood stabilizer, antidepressant should not mood stabilizer, antidepressant should not be consideredbe considered
If using anticonvulsants, it is important to If using anticonvulsants, it is important to ensure that the patient is at a therapeutic ensure that the patient is at a therapeutic dose determined by blood level before dose determined by blood level before declaring the failuredeclaring the failure
Measure lithium level to assess adequate Measure lithium level to assess adequate dosingdosing
GUIDELINES FOR TREATMENT GUIDELINES FOR TREATMENT OF BIPOLAR DISORDEROF BIPOLAR DISORDER
Identify and manage symptoms that Identify and manage symptoms that destabilize illnessdestabilize illness
1. Sleep disturbance1. Sleep disturbance2. Anxiety2. Anxiety3. Psychosocial stressors3. Psychosocial stressors4. Co-morbid condition4. Co-morbid condition
GUIDELINES FOR TREATMENT GUIDELINES FOR TREATMENT OF BIPOLAR DISORDEROF BIPOLAR DISORDER
Restore psychosocial functioningRestore psychosocial functioning
Educate patient and significant othersEducate patient and significant others
Monitor patient and recognize that the course may Monitor patient and recognize that the course may change over timechange over time
Utilize life chartingUtilize life charting
GUIDELINES FOR TREATMENT GUIDELINES FOR TREATMENT OF BIPOLAR DISORDEROF BIPOLAR DISORDER
Accurate diagnosis-remission and ultimate Accurate diagnosis-remission and ultimate recoveryrecovery
Treat entire illness, not just episodeTreat entire illness, not just episode
Individual treatmentIndividual treatment
Explore aggressive treatment strategies (eg Explore aggressive treatment strategies (eg loading strategies, ER formulations )loading strategies, ER formulations )
GUIDELINES FOR TREATMENT GUIDELINES FOR TREATMENT OF BIPOLAR DISORDEROF BIPOLAR DISORDER
Utilize medications that optimize efficacy, Utilize medications that optimize efficacy, safety, tolerability, and adherencesafety, tolerability, and adherence
- Maximize mood stabilizer, including Maximize mood stabilizer, including combination therapycombination therapy
- Use anxiolytics/hypnotics, atypical Use anxiolytics/hypnotics, atypical neuroleptics and novel anticonvulsants as neuroleptics and novel anticonvulsants as adjunctive therapy to mood stabilizeradjunctive therapy to mood stabilizer
- Use brief, acute, intermittent Use brief, acute, intermittent antidepressant therapyantidepressant therapy
COMBINATION COMBINATION TREATMENTTREATMENT
Predictors for potential need for combination Predictors for potential need for combination therapytherapy....
-Acute mania-Acute mania-Mixed states-Mixed states-Depressive components-Depressive components-Rapid cycling-Rapid cycling-Psychosis-Psychosis-Severity of illness-Severity of illness-Increasing age-Increasing age-Prior hospitalization-Prior hospitalization
COMBINATION COMBINATION TREATMENTTREATMENT
Commonly effective combination therapyCommonly effective combination therapy1. Lithium plus divalproex1. Lithium plus divalproex2. an atypical plus lithium/divalproex2. an atypical plus lithium/divalproex3. an antipsychotic plus divalproex3. an antipsychotic plus divalproex
COMBINATION COMBINATION TREATMENTTREATMENT
Once the patient is stabilized, it becomes Once the patient is stabilized, it becomes more important to look at what treatments more important to look at what treatments may not be playing such an important rolemay not be playing such an important role
Combination therapy has become Combination therapy has become commonplace in the treatment of bipolar commonplace in the treatment of bipolar disorder and further studies will provide disorder and further studies will provide data on efficacy, safety and tolerability of data on efficacy, safety and tolerability of combination treatments during long term combination treatments during long term treatmenttreatment
SUMMARYSUMMARY
Diagnosis and treatment of bipolar Diagnosis and treatment of bipolar disorder, particularly mixed state can be disorder, particularly mixed state can be very difficult and has serious implicationsvery difficult and has serious implications
When choosing a treatment regimen, When choosing a treatment regimen, medications that optimizes efficacy, safety, medications that optimizes efficacy, safety, tolerability, and adherence should be tolerability, and adherence should be prioritizedprioritized